Researchers probe microbiome-cancer treatment link

by Nathan Collins,Stanford UniversityCredit: CC0 Public DomainCancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immun

Updated on: June 06,2024

Researchers probe microbiome-cancer treatment link

by Nathan Collins,Stanford UniversityCredit: CC0 Public DomainCancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immun

Updated on:June 06,2024

Circulating tumor cell count guidance may improve long-term outcomes for patients with metastatic breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainThe use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-

Updated on: January 22,2024

Circulating tumor cell count guidance may improve long-term outcomes for patients with metastatic breast cancer

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainThe use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-

Updated on:January 22,2024

Incidence of Hodgkin lymphoma up in least deprived areas

Individuals living in the most affluent areas of the United Kingdom seem to have an increased incidence of Hodgkin lymphoma (HL), according to a study published in the August issue ofBMJ Open.Me

Updated on: March 21,2024

Incidence of Hodgkin lymphoma up in least deprived areas

Individuals living in the most affluent areas of the United Kingdom seem to have an increased incidence of Hodgkin lymphoma (HL), according to a study published in the August issue ofBMJ Open.Me

Updated on:March 21,2024

This 'sweet spot' could improve melanoma diagnosis

by Florida Atlantic UniversityMelanoma image example: original, i.e., no segmentation (f) and five degrees of segmentation -- from (a) through (e). Credit: Florida Atlantic UniversityToo much, to

Updated on: April 18,2024

This 'sweet spot' could improve melanoma diagnosis

by Florida Atlantic UniversityMelanoma image example: original, i.e., no segmentation (f) and five degrees of segmentation -- from (a) through (e). Credit: Florida Atlantic UniversityToo much, to

Updated on:April 18,2024

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti

Updated on: September 10,2024

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti

Updated on:September 10,2024

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Updated on: September 27,2024

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Updated on:September 27,2024

Sugar modifications the key to unlocking ovarian cancer secrets

byGriffith UniversityOvarian cancer research. Credit: Griffith UniversityThe ability to identify unique sugars that decorate ovarian cancer cells could help prevent the spread of cancer and impr

Updated on: January 07,2024

Sugar modifications the key to unlocking ovarian cancer secrets

byGriffith UniversityOvarian cancer research. Credit: Griffith UniversityThe ability to identify unique sugars that decorate ovarian cancer cells could help prevent the spread of cancer and impr

Updated on:January 07,2024

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente

Updated on: March 25,2024

Scientists develop a new type of anti-cancer agent

JANUARY 31, 2024by Center for Research in Biological Chemistry and Molecular Materials (CiQUS)Cancer stem cells, marked in red, disappear in the presence of the reference compound (Ru1). Credit: Cente

Updated on:March 25,2024

New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

byHelmholtz Association of German Research CentresmCSF1R CART do not cause toxicity in mice. Credit:Nature Biotechnology(2023). https://doi.org/10.1038/s41587-023-01684-0Unlike other

Updated on: January 07,2024

New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

byHelmholtz Association of German Research CentresmCSF1R CART do not cause toxicity in mice. Credit:Nature Biotechnology(2023). https://doi.org/10.1038/s41587-023-01684-0Unlike other

Updated on:January 07,2024

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on: December 28,2023

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Updated on:December 28,2023

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T

Updated on: November 09,2024

Cilta-cel found highly effective in first real-world study of patients with relapsed or refractory multiple myeloma

byAmerican Society of HematologyCredit: Pixabay/CC0 Public DomainIn the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T

Updated on:November 09,2024

Researchers show xCT protein is key link in inhibiting pancreatic cancer growth and limiting mood disturbances

by Vrije Universiteit BrusselCredit: Pixabay/CC0 Public DomainThe xCT protein, which plays an important role as a transport molecule in cells, could play a part in cancer treatment in the future, rese

Updated on: March 28,2024

Researchers show xCT protein is key link in inhibiting pancreatic cancer growth and limiting mood disturbances

by Vrije Universiteit BrusselCredit: Pixabay/CC0 Public DomainThe xCT protein, which plays an important role as a transport molecule in cells, could play a part in cancer treatment in the future, rese

Updated on:March 28,2024